167 related articles for article (PubMed ID: 26141231)
1. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
Furfaro LL; Spiller OB; Keelan JA; Payne MS
Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
[TBL] [Abstract][Full Text] [Related]
2. Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection.
Miura Y; Payne MS; Keelan JA; Noe A; Carter S; Watts R; Spiller OB; Jobe AH; Kallapur SG; Saito M; Stock SJ; Newnham JP; Kemp MW
Antimicrob Agents Chemother; 2014 Sep; 58(9):5413-20. PubMed ID: 24982089
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
[TBL] [Abstract][Full Text] [Related]
4. Results from the Solithromycin International Surveillance Program (2014).
Farrell DJ; Flamm RK; Sader HS; Jones RN
Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551
[TBL] [Abstract][Full Text] [Related]
5. Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.
Keelan JA; Kemp MW; Payne MS; Johnson D; Stock SJ; Saito M; Fernandes P; Newnham JP
Antimicrob Agents Chemother; 2014; 58(1):447-54. PubMed ID: 24189250
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
Putnam SD; Sader HS; Farrell DJ; Biedenbach DJ; Castanheira M
Int J Antimicrob Agents; 2011 Jan; 37(1):39-45. PubMed ID: 21075602
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
Jensen JS; Fernandes P; Unemo M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3151-6. PubMed ID: 24637681
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.
Hawser S; Morrissey I; Lemos B; Keedy K; Fernandes P
Int J Antimicrob Agents; 2017 Jul; 50(1):17-22. PubMed ID: 28483717
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
10. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of solithromycin against anaerobic bacteria from the normal intestinal microbiota.
Weintraub A; Rashid MU; Nord CE
Anaerobe; 2016 Dec; 42():119-122. PubMed ID: 27725229
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
Piccinelli G; Fernandes P; Bonfanti C; Caccuri F; Caruso A; De Francesco MA
Antimicrob Agents Chemother; 2014; 58(3):1693-8. PubMed ID: 24379197
[TBL] [Abstract][Full Text] [Related]
13. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.
Mallegol J; Fernandes P; Melano RG; Guyard C
Antimicrob Agents Chemother; 2014; 58(2):909-15. PubMed ID: 24277019
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.
Govender S; Gqunta K; le Roux M; de Villiers B; Chalkley LJ
J Antimicrob Chemother; 2012 Dec; 67(12):2821-4. PubMed ID: 22879459
[TBL] [Abstract][Full Text] [Related]
16. Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Biedenbach DJ; Castanheira M; Jones RN
Antimicrob Agents Chemother; 2010 Sep; 54(9):4009-11. PubMed ID: 20625152
[TBL] [Abstract][Full Text] [Related]
17. Current understanding and treatment of intra-amniotic infection with Ureaplasma spp.
Tantengco OAG; Yanagihara I
J Obstet Gynaecol Res; 2019 Sep; 45(9):1796-1808. PubMed ID: 31313469
[TBL] [Abstract][Full Text] [Related]
18. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
Farrell DJ; Castanheira M; Sader HS; Jones RN
J Infect; 2010 Dec; 61(6):476-83. PubMed ID: 20831882
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of enacyloxin IIa and gladiolin against the urogenital pathogens Neisseria gonorrhoeae and Ureaplasma spp.
Heath NL; Rowlands RS; Webster G; Mahenthiralingam E; Beeton ML
J Appl Microbiol; 2021 May; 130(5):1546-1551. PubMed ID: 32966677
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
Beeton ML; Chalker VJ; Jones LC; Maxwell NC; Spiller OB
Antimicrob Agents Chemother; 2016 Jan; 60(1):52-6. PubMed ID: 26459899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
